Abbott Laboratories - Company Profile
Powered by
All the data and insights you need on Abbott Laboratories in one report.
$295
- Save hours of research time and resources with
our up-to-date Abbott Laboratories Strategy Report
- Understand Abbott Laboratories position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreView up-to-date information on Abbott Laboratories’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
24 May 2022 | Abbott Operations Uruguay Enters into Licensing Agreement with Shanghai Henlius Biotech | Licensing Agreement |
Abbott Operations Uruguay Srl
|
Shanghai Henlius Biotech Inc |
27 Apr 2022 | Ypsomed Holdings, Abbott Labs and CamDiab Enter into Agreement | Partnership | - |
Ypsomed Holding AG Abbott Laboratories
CamDiab Ltd
|
02 Sep 2021 | Abbott Labs Acquires Walk Vascular | Acquisition |
Abbott Laboratories
|
Walk Vascular, LLC
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer